openPR Logo
Press release

Investigation announced for Long-Term Investors in shares of Zynex, Inc. (NASDAQ: ZYXI) over potential Wrongdoing

An investigation on behalf of current long term investors in Zynex, Inc. (NASDAQ: ZYXI) shares.

An investigation on behalf of current long term investors in Zynex, Inc. (NASDAQ: ZYXI) shares.

An investigation was announced for long-term investors in shares of Zynex, Inc. (NASDAQ: ZYXI) concerning potential breaches of fiduciary duties by certain directors of Zynex, Inc.

Investors who are current long term investors in Zynex, Inc. (NASDAQ: ZYXI) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long term investors in Zynex, Inc. (NASDAQ: ZYXI stocks follows a lawsuit filed against Zynex, Inc. (NASDAQ: ZYXI over alleged securities laws violations. The investigation on behalf of current long term investors in Zynex, Inc. (NASDAQ: ZYXI stocks, concerns whether certain Zynex, Inc. (NASDAQ: ZYXI officers and directors are liable in connection with the allegations made in that lawsuit.

According to that complaint filed in the U.S. District Court for the District of Colorado the plaintiff alleges that, the Defendants failed to disclose to investors that Zynex shipped products, including electrodes, in excess of need, that, as a result of this practice, the Company inflated its revenue, that the Company's practice of filing false claims drew scrutiny from insurers, including Tricare, that, as a result, it was reasonably likely that Zynex would face adverse consequences, including removal from insurer networks and penalties from the federal government, and that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Those who purchased shares of Zynex, Inc. (NASDAQ: ZYXI) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Long-Term Investors in shares of Zynex, Inc. (NASDAQ: ZYXI) over potential Wrongdoing here

News-ID: 4041113 • Views:

More Releases from Shareholders Foundation, Inc.

Investigation announced for Long-Term Investors in shares of PepGen Inc. (NASDAQ: PEPG) over potential Wrongdoing
Investigation announced for Long-Term Investors in shares of PepGen Inc. (NASDAQ …
An investigation was announced for current long-term investors in shares of PepGen Inc. (NASDAQ: PEPG) concerning potential breaches of fiduciary duties by certain directors of PepGen Inc. Investors who are current long term investors in PepGen Inc. (NASDAQ: PEPG) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: PEPG
Novo Nordisk A/S (NYSE: NVO) Investor Alert: Lawsuit alleges False and Misleading Statements
Novo Nordisk A/S (NYSE: NVO) Investor Alert: Lawsuit alleges False and Misleadin …
An investor, who purchased shares of Novo Nordisk A/S (NYSE: NVO), filed a lawsuit in the U.S. District Court for the District of New Jersey over alleged violations of Federal Securities Laws by Novo Nordisk A/S in connection with certain allegedly false and misleading statements. Investors who purchased shares of Novo Nordisk A/S (NYSE: NVO) have certain options and for certain investors are short and strict deadlines running. Deadline: September 30,
Lawsuit filed for Investors who lost money with shares of PubMatic, Inc. (NASDAQ: PUBM)
Lawsuit filed for Investors who lost money with shares of PubMatic, Inc. (NASDAQ …
An investor, who purchased shares of PubMatic, Inc. (NASDAQ: PUBM), filed a lawsuit over alleged violations of Federal Securities Laws by PubMatic, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of PubMatic, Inc. (NASDAQ: PUBM) have certain options and for certain investors are short and strict deadlines running. Deadline: October 20, 2025. NASDAQ: PUBM investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)
Reckitt Benckiser Group plc (OTC: RBGLY) Long Term Investor Alert: Investigation of potential Wrongdoing
Reckitt Benckiser Group plc (OTC: RBGLY) Long Term Investor Alert: Investigation …
An investigation on behalf of current long-term investors in shares of Reckitt Benckiser Group plc (OTC: RBGLY) concerning potential breaches of fiduciary duties was announced. Investors who are current long term investors in Reckitt Benckiser Group plc (OTC: RBGLY) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in OTC: RBGLY

All 5 Releases


More Releases for Zynex

Electric Stimulation Devices Market Size, Competitive Outlook Medtronic, Zynex, …
Electric stimulation devices (ESDs) use electrical impulses to stimulate nerves and muscles for therapeutic purposes. These devices are widely used in pain management, rehabilitation, and muscle conditioning. They function by emitting controlled electrical currents through electrodes placed on the skin, which can help reduce muscle spasms, improve blood circulation, and promote tissue healing. Some devices, like Transcutaneous Electrical Nerve Stimulation (TENS) units, are designed to block pain signals to the
Muscle Stimulator Market Next Big Thing | Major Giants- Axiobionics, Zynex, Neur …
Pro Market Reports published a new research publication on "Muscle Stimulator Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Muscle Stimulator market was mainly driven by the increasing R&D spending across the world. Some of the key players profiled in
Pain Management Device Market May See Big Move: Medtronic, Cyberonics, Zynex
The latest study released on the Global Pain Management Device Market by HTF MI evaluates market size, trend, and forecast to 2030. The Pain Management Device market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors. Key
Investigation announced for Investors in Zynex, Inc. (NASDAQ: ZYXI) over potenti …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Zynex, Inc. Investors who purchased shares of Zynex, Inc. (NASDAQ: ZYXI) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Zynex, Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders. Englewood, CO based Zynex,
Investigation announced for Investors in shares of Zynex, Inc. (NASDAQ: ZYXI)
An investigation was announced on behalf of investors of Zynex, Inc. (NASDAQ: ZYXI) shares over potential securities laws violations by Zynex, Inc. Investors who purchased shares of Zynex, Inc. (NASDAQ: ZYXI), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Zynex, Inc. (NASDAQ: ZYXI) concerning whether
Neuro-Stimulators Market Analysis, Research Study With NeuroMetrix, Zynex, Nevro
Neuro-stimulators are a new way of controlling devices through the mind. Neuro-stimulators have a lot of different uses and they can be used to control (or set) everything from your TV remote, to steering wheel in your car, or even building elevators. The latest Neuro-Stimulators market research report is now available for you to review by A2Z Market Research. The report begins with an introduction to the Neuro-Stimulators market, including its